Molecular Diagnostics

Molecular diagnostics is being applied to an increasingly wide range of applications in infectious disease, oncology, and genetic disease diagnosis and screening, and to a number of emerging applications. The market for molecular diagnostics products totaled nearly $21bn in 2021. Following a projected downturn in 2022 and 2023 due to a decline in COVID-19 testing, the market is expected to return to growth in 2024. Drivers of the market will include adoption of new types of tests, expansion of target populations for molecular testing, and advances in the level of diagnostic testing services provided, particularly in developing countries. 

This new report from Meddevicetracker includes a discussion of products, current/forecast markets, competitors, and opportunities in the molecular diagnostics products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets. The forecast range for this report is 2021–26.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].

Related Medtech Insight and HBW Insight articles:

• May 2, 2022 - FDA Expands OPEQ ‘Super Office’; Splits In Vitro Diagnostics, Radiological Health Office In Two
• May 16, 2022 - FDA Allows 510(k)s For HIV Diagnostics
• June 7, 2022 - Expected Spread Of US OTC Diagnostics Could Change Consumers’ Health Care Behaviors
• Subscribe to Medtech Insight to view these articles and more!